1-154567990-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000748.3(CHRNB2):c.-55C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0041 in 1,470,084 control chromosomes in the GnomAD database, including 232 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 143 hom., cov: 32)
Exomes 𝑓: 0.0020 ( 89 hom. )
Consequence
CHRNB2
NM_000748.3 5_prime_UTR
NM_000748.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.202
Genes affected
CHRNB2 (HGNC:1962): (cholinergic receptor nicotinic beta 2 subunit) Neuronal acetylcholine receptors are homo- or heteropentameric complexes composed of homologous alpha and beta subunits. They belong to a superfamily of ligand-gated ion channels which allow the flow of sodium and potassium across the plasma membrane in response to ligands such as acetylcholine and nicotine. This gene encodes one of several beta subunits. Mutations in this gene are associated with autosomal dominant nocturnal frontal lobe epilepsy. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 1-154567990-C-T is Benign according to our data. Variant chr1-154567990-C-T is described in ClinVar as [Benign]. Clinvar id is 670849.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0771 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNB2 | NM_000748.3 | c.-55C>T | 5_prime_UTR_variant | 1/6 | ENST00000368476.4 | NP_000739.1 | ||
CHRNB2 | XR_001736952.3 | n.213C>T | non_coding_transcript_exon_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNB2 | ENST00000368476 | c.-55C>T | 5_prime_UTR_variant | 1/6 | 1 | NM_000748.3 | ENSP00000357461.3 | |||
CHRNB2 | ENST00000637900 | c.-55C>T | 5_prime_UTR_variant | 1/6 | 5 | ENSP00000490474.1 | ||||
CHRNB2 | ENST00000636034.1 | n.-55C>T | non_coding_transcript_exon_variant | 1/9 | 5 | ENSP00000489703.1 | ||||
CHRNB2 | ENST00000636034.1 | n.-55C>T | 5_prime_UTR_variant | 1/9 | 5 | ENSP00000489703.1 |
Frequencies
GnomAD3 genomes AF: 0.0223 AC: 3401AN: 152174Hom.: 142 Cov.: 32
GnomAD3 genomes
AF:
AC:
3401
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00199 AC: 2617AN: 1317802Hom.: 89 Cov.: 27 AF XY: 0.00166 AC XY: 1077AN XY: 649358
GnomAD4 exome
AF:
AC:
2617
AN:
1317802
Hom.:
Cov.:
27
AF XY:
AC XY:
1077
AN XY:
649358
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0224 AC: 3410AN: 152282Hom.: 143 Cov.: 32 AF XY: 0.0207 AC XY: 1538AN XY: 74456
GnomAD4 genome
AF:
AC:
3410
AN:
152282
Hom.:
Cov.:
32
AF XY:
AC XY:
1538
AN XY:
74456
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 14, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at